|
Contact Person: Kristin Martin, Executive Director 205/903-9574 E-mail: k.martin@thinkoflaura.org May 5, 2010 For Immediate Release LPGA Player Eagles Against Ovarian Cancer The Laura Crandall Brown Ovarian Cancer Foundation, based in Birmingham and reaching patients in Alabama and Georgia, is pleased to announce its affiliation with Jean Reynolds of Newnan, Georgia, who will be playing in Bell Micro Ladies Professional Golf Association's (LPGA) Golf Tournament on May 13-16. Jean, in her rookie year on the LPGA Tour, is representing the Foundation and this important cause due to personal experiences. Jean earned her LPGA Tour card by winning two tournaments on the Duramed Futures Tour (the LPGA's development tour) and then finishing 2nd on the Money List last year. She also thrilled many golf fans in the southeast when she flirted with winning the U.S. Women's Open before finishing 17th. A five-time winner of the Georgia State Golf Association (GSGA) Championship, Jean was a member of the 2005 United States Golf Association (USGA) State Championship team, representing Georgia. She graduated from the University of Georgia, where she deliberately chose not to play on the golf team in order to have a "normal" student experience. It did not take Jean long to get her game back up to speed after graduating. She turned professional in 2007. Jean and her brother grew up in Newnan with Laura Crandall Brown's husband, Walter. After hearing Laura's story, Jean was compelled to use her LPGA platform to raise awareness about ovarian cancer. She joins the Laura Crandall Brown Ovarian Cancer Foundation in promoting research for an early diagnostic method for this silent disease. "This is a very exciting year for me playing on the LPGA tour. I am thrilled to be playing a sport I love while calling attention to an important cause, such as ovarian cancer," Reynolds said recently during a break from the links. She continued, "I am pleased to have the opportunity to raise awareness of this disease that strikes silently and sometimes without much warning. Until a reliable screening test is developed, it is important for women to know the symptoms and discuss them with their doctors. Early detection leads to better treatment." Early detection leads to early treatment and better outcomes. One in 69 women will face ovarian cancer in their lifetime. In 2009, over 21,000 cases were diagnosed and over 14,000 women died from this silent killer. The Laura Crandall Brown Ovarian Cancer Foundation strives to improve those odds and offer hope and support to all women and those who love them. The Laura Crandall Brown Ovarian Cancer Foundation was founded in December 2009 in honor of Laura who expressed her desire to be able to help others afflicted by ovarian cancer. Through her foundation, we strive to carry out Laura's legacy, which is our mission, to raise awareness and fund research specifically in the area of early detection. For more information, please visit the website at http://www.thinkoflaura.org/ or by calling Kristin Martin at 205/903-9574. ###
|
